Trump predicts that the United States will develop a vaccine by the end of the year

　　China News Service, May 4 (Xinhua) According to the Associated Press, on May 3, US President Trump said that the United States will receive a new crown vaccine by the end of 2020. However, the US media pointed out that Trump seemed to admit in his subsequent speech that his predictions were somewhat "ambitious" and pointed out that medical experts may advise him not to make such a statement.

　　On the evening of May 3, local time, Trump made this point of view on a show on Forbes News. Trump told a Nebraska man recovering from the new coronavirus: "We think that we will have the vaccine by the end of this year."

Data graph: US President Trump. China News Agency reporter Chen Meng Tongshe

　　However, the US "Capitol Hill" reported that Trump seemed to admit that his prediction looked a bit "ambitious" and pointed out that medical experts may advise him not to make such a statement.

　　According to reports, Trump later said: "Doctors will say, 'Well, you shouldn't say that.' (But) I want to say whatever I want." Trump also pointed out that he had worked with vaccines Executives of the developed company met and said, "I think we will have a vaccine soon."

　　According to previous media reports, the WHO has stated that the vaccine is expected to be ready within 18 months, which is an unprecedented rate. American health experts also emphasized that it is expected that there will be a vaccine in another year or more.

　　The Associated Press report also pointed out that Trump said that the US government is fully supporting the study of the drug Remdesivir to treat patients with new crowns. Redcive is an antiviral drug developed by Gilead Technology in the United States. It was originally planned to treat diseases such as Ebola hemorrhagic fever and Middle East respiratory syndrome. It has not yet been approved for marketing in any country in the world.

　　It is reported that the U.S. government issued an emergency use authorization on May 1 to allow a drug still in the research stage, redoxivir, for the treatment of patients with severe new crowns.